Supplementary Tables 1 - 3, Figures 1 - 4 from Phase II Study of Cetuximab in Combination with Cisplatin and Radiation in Unresectable, Locally Advanced Head and Neck Squamous Cell Carcinoma: Eastern Cooperative Oncology Group Trial E3303

Autor: Arlene A. Forastiere, Barbara A. Burtness, Urjeet A. Patel, John Andrew Ridge, Ranee Mehra, Donghua Yang, Athanassios Argiris, Dong M. Shin, Lin Wang, Raja R. Seethala, Jennifer R. Grandis, Alec Vaezi, Harry Quon, Corey J. Langer, Ju-Whei Lee, Ann Marie Egloff
Rok vydání: 2023
Popis: Supplemental Table 1. Criteria for Unresectable Disease Supplemental Table 2. Modified RECIST Criteria for Head and Neck Cancer. Supplemental Table 3. Summary of Serum Analyte Levels. Supplemental Figure 1. Study Schematic Supplemental Figure 2. Time to locoregional failure for all eligible and treated patients (a) and by tumor HPV status (b). Log rank test comparing time to failure for HPV+ versus HPV- p value provided. Supplemental Figure 3. Representative tissue cores with high or low expression levels of XPF or ERCC1 as assessed by AQUA. Tumors were stained for cytokeratin (CK) to create a tumor mask and with DAPI to define the nuclear compartment. Supplemental Figure 4. Representative tumor IHC molecular correlates ERCC1, XPF and MET.
Databáze: OpenAIRE